| Comprehensive molecular characterization of urothelial bladder carcinoma Cancer Genome Atlas Research Network Nature 507 (7492), 315, 2014 | 2597 | 2014 |
| Comprehensive molecular characterization of muscle-invasive bladder cancer AG Robertson, J Kim, H Al-Ahmadie, J Bellmunt, G Guo, AD Cherniack, ... Cell 171 (3), 540-556. e25, 2017 | 2208 | 2017 |
| Bladder cancer AM Kamat, NM Hahn, JA Efstathiou, SP Lerner, PU Malmström, W Choi, ... The Lancet 388 (10061), 2796-2810, 2016 | 1241 | 2016 |
| Systematic review of complications of prostate biopsy S Loeb, A Vellekoop, HU Ahmed, J Catto, M Emberton, R Nam, ... European urology 64 (6), 876-892, 2013 | 1154 | 2013 |
| BAP1 loss defines a new class of renal cell carcinoma S Peña-Llopis, S Vega-Rubín-de-Celis, A Liao, N Leng, A Pavía-Jiménez, ... Nature genetics 44 (7), 751-759, 2012 | 977 | 2012 |
| Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO guideline SS Chang, BH Bochner, R Chou, R Dreicer, AM Kamat, SP Lerner, ... The Journal of urology 198 (3), 552-559, 2017 | 853 | 2017 |
| Epidemiology of stone disease across the world I Sorokin, C Mamoulakis, K Miyazawa, A Rodgers, J Talati, Y Lotan World journal of urology 35, 1301-1320, 2017 | 828 | 2017 |
| Bladder cancer O Sanli, J Dobruch, MA Knowles, M Burger, M Alemozaffar, ME Nielsen, ... Nature reviews Disease primers 3 (1), 1-19, 2017 | 828 | 2017 |
| Recurrence and progression of disease in non–muscle-invasive bladder cancer: from epidemiology to treatment strategy BWG Van Rhijn, M Burger, Y Lotan, E Solsona, CG Stief, RJ Sylvester, ... European urology 56 (3), 430-442, 2009 | 821 | 2009 |
| Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018 MGK Cumberbatch, I Jubber, PC Black, F Esperto, JD Figueroa, ... European urology 74 (6), 784-795, 2018 | 758 | 2018 |
| Comprehensive molecular characterization of pheochromocytoma and paraganglioma L Fishbein, I Leshchiner, V Walter, L Danilova, AG Robertson, ... Cancer cell 31 (2), 181-193, 2017 | 625 | 2017 |
| Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses Y Lotan, CG Roehrborn Urology 61 (1), 109-118, 2003 | 609 | 2003 |
| Climate-related increase in the prevalence of urolithiasis in the United States TH Brikowski, Y Lotan, MS Pearle Proceedings of the National Academy of Sciences 105 (28), 9841-9846, 2008 | 537 | 2008 |
| The economics of bladder cancer: costs and considerations of caring for this disease RS Svatek, BK Hollenbeck, S Holmäng, R Lee, SP Kim, A Stenzl, Y Lotan European urology 66 (2), 253-262, 2014 | 534 | 2014 |
| Three differentiation states risk-stratify bladder cancer into distinct subtypes JP Volkmer, D Sahoo, RK Chin, PL Ho, C Tang, AV Kurtova, ... Proceedings of the National Academy of Sciences 109 (6), 2078-2083, 2012 | 374 | 2012 |
| The new economics of radical prostatectomy: cost comparison of open, laparoscopic and robot assisted techniques Y Lotan, JA Cadeddu, MT Gettman The Journal of urology 172 (4 Part 1), 1431-1435, 2004 | 365 | 2004 |
| Spectrum of diverse genomic alterations define non–clear cell renal carcinoma subtypes S Durinck, EW Stawiski, A Pavía-Jiménez, Z Modrusan, P Kapur, ... Nature genetics 47 (1), 13-21, 2015 | 359 | 2015 |
| Use of the National Health and Nutrition Examination Survey to calculate the impact of obesity and diabetes on cost and prevalence of urolithiasis in 2030 JA Antonelli, NM Maalouf, MS Pearle, Y Lotan European urology 66 (4), 724-729, 2014 | 344 | 2014 |
| Cost comparison of robotic, laparoscopic, and open radical prostatectomy for prostate cancer C Bolenz, A Gupta, T Hotze, R Ho, JA Cadeddu, CG Roehrborn, Y Lotan European urology 57 (3), 453-458, 2010 | 343 | 2010 |
| A gain-of-function mutation in DHT synthesis in castration-resistant prostate cancer KH Chang, R Li, B Kuri, Y Lotan, CG Roehrborn, J Liu, R Vessella, ... Cell 154 (5), 1074-1084, 2013 | 338 | 2013 |
